AIM Supports Senator Blunt's Re-Election for His Commitment in the Fight to End Alzheimer's

WASHINGTON, D.C., October 29, 2016 - In appreciation and acknowledgement of Senator Roy Blunt's (R-MO) continued leadership in the fight to end Alzheimer's, the Alzheimer's Impact Movement (AIM) is...

Read More

AIM Thanks Senator Murray for Her Commitment in the Fight to End Alzheimer's

WASHINGTON, D.C., October 29, 2016 - In recognition and appreciation of Senator Patty Murray's (D-WA) efforts in the fight to end Alzheimer's the Alzheimer's Impact Movement (AIM) is supporting her re...

Read More

Medicare to Pay for Cognitive Assessment and Care Planning for Persons with Alzheimer's Disease

WASHINGTON, D.C., November 3, 2016 - The Alzheimer's Impact Movement (AIM) is celebrating the final decision by the Centers for Medicare & Medicaid Services (CMS) to improve access to care and support...

Read More

AIM Celebrates Passage of 21st Century Cures Act

WASHINGTON, D.C., December 7, 2016 - Following action taken by the House of Representatives, the Senate today voted to pass the 21st Century Cures Act, which would secure additional funding at the...

Read More

Bipartisan Legislation Will Strengthen the Nation's Commitment to Addressing Alzheimer's

The Alzheimer's Association and the Alzheimer's Impact Movement (AIM) are proud to support the bipartisan NAPA Reauthorization Act and the Alzheimer's Accountability and Investment Act. Introduced in...

Read More

Pathway to Treatments Through Accelerated Approvals

This week, the Alzheimer's Association sponsored, and the Hill hosted, a discussion on accelerated approval with policymakers, experts and patient advocates. Through the Food and Drug Administration's...

Read More

Securing Critical Funding for Alzheimer’s and Other Dementia Research

Earlier this month, a $289 million increase in funding for Alzheimer's and other dementia research at the National Institutes of Health (NIH) was approved by Congress and signed into law by President...

Read More

For Individuals with Early-Stage Alzheimer’s Disease: A Decision With Devastating Repercussions

For people living with mild cognitive impairment (MCI) due to Alzheimer's disease, the Centers for Medicare & Medicaid Services (CMS) proposal to sharply limit access to current and future treatments...

Read More

Patient Perspective: The Clock is Ticking for People Living with Alzheimer’s

For people living with early-stage Alzheimer's disease like Mike Zuendel, the clock is ticking after the Centers for Medicare & Medicaid Services (CMS) draft decision that effectively denies access to...

Read More

Fighting for Folks Like Me

This article originally appeared in the 2022 Impact Report. Become a member today to get access to additional exclusive content, meetings and insights into the Alzheimer's and dementia public policy...

Read More